Österdahl, Marc F.
Whiston, Ronan
Sudre, Carole H.
Asnicar, Francesco
Cheetham, Nathan J.
Blanco Miguez, Aitor
Bowyer, Vicky
Antonelli, Michela
Snell, Olivia
dos Santos Canas, Liane
Hu, Christina
Wolf, Jonathan
Menni, Cristina
Malim, Michael
Hart, Deborah
Spector, Tim
Berry, Sarah
Segata, Nicola
Doores, Katie
Ourselin, Sebastien
Duncan, Emma L.
Steves, Claire J.
Funding for this research was provided by:
Chronic Disease Research Foundation (CDRF 22/2020, CDRF 22/2020, CDRF 22/2020, CDRF 22/2020, CDRF 22/2020, CDRF 22/2020, CDRF 22/2020, CDRF 22/2020, CDRF 22/2020)
Centre For Medical Engineering, King’s College London (WT 203148/Z/16/Z, WT 203148/Z/16/Z, WT 203148/Z/16/Z, WT 203148/Z/16/Z)
Wellcome Trust (215010/Z/18/Z, 215010/Z/18/Z, 215010/Z/18/Z)
3IA Côte d'Azur Investments in the Future (ANR-19-P3IA-0002)
Article History
Received: 3 November 2022
Accepted: 4 May 2023
First Online: 27 June 2023
Competing interests
: TDS is a shareholder and cofounder of ZOE Global Ltd, and has received payment for scientific consultancy services to ZOE Global Ltd. JW and CH are employees of ZOE Global Ltd. No other authors have competing interests to declare.